- Home
- / Arno Therapeutics
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Arno Therapeutics financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$0
2022-08-02
Market Capitalization
$177.7 K
2022-08-02
CreditSafe Score
?
Score changed on Jun 09, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2013 | FY, 2014 | FY, 2015 |
|---|---|---|---|
| General and administrative expense | 3.5M | 6.7M | 4.8M |
| Operating expense total | 16.9M | 21.5M | 13.4M |
| EBIT | (16.9M) | (21.5M) | (13.4M) |
| Interest income | 17.7K | 42.0K | 7.7K |
| Interest expense | 18.6M | 143.0 | 28.4K |
| Net Income | (39.7M) | 7.8M | (11.5M) |